Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...
BDX seeks CE Mark for its Liverty TIPS Stent Graft, a next-gen device aimed at improving portal hypertension treatment and ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced application of ...
Subharmonic aided pressure estimation (SHAPE) represents an emerging noninvasive technique that leverages the nonlinear acoustic properties of ultrasound contrast agents to estimate pressure in ...
Please provide your email address to receive an email when new articles are posted on . Sustained virologic response occurred in 81.8% of patients after the first DAA treatment course. Despite this, ...
Chinese Medical Journals Publishing House Co., Ltd. Portal hypertension, a life-threatening complication of cirrhosis affecting millions globally, has seen paradigm shifts with the release of the ...
A new review highlights how combining multiple ultrasound techniques may help detect and assess portal hypertension in ...
The progressive worsening of liver cirrhosis and portal hypertension (HTN) decreases intra-hepatic nitric oxide (NO), which is counterbalanced by increased NO secretion from adjacent endothelial cells ...
Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...
BD (Becton, Dickinson and Company) announced European CE Mark approval for the Liverty transjugular intrahepatic portosystemic sh ...
NORCROSS, Ga., March 31, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results